Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.

Fifis T, Nguyen L, Malcontenti-Wilson C, Chan LS, Nunes Costa PL, Daruwalla J, Nikfarjam M, Muralidharan V, Waltham M, Thompson EW, Christophi C.

Cancer Med. 2013 Oct;2(5):595-610. doi: 10.1002/cam4.109. Epub 2013 Aug 18.

2.

Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments.

Nguyen L, Fifis T, Malcontenti-Wilson C, Chan LS, Costa PN, Nikfarjam M, Muralidharan V, Christophi C.

BMC Cancer. 2012 Nov 15;12:522. doi: 10.1186/1471-2407-12-522.

3.

Hyperbaric oxygen therapy reduces the severity of ischaemia, preservation and reperfusion injury in a rat model of liver transplantation.

Tran NQ, Malcontenti-Wilson C, Hammoud S, Millar I, Christophi C, Muralidharan V.

HPB (Oxford). 2012 Feb;14(2):103-14. doi: 10.1111/j.1477-2574.2011.00410.x. Epub 2011 Nov 13.

4.

Induction of Th1Immune responses following laser ablation in a murine model of colorectal liver metastases.

Lin WX, Fifis T, Malcontenti-Wilson C, Nikfarjam M, Muralidharan V, Nguyen L, Christophi C.

J Transl Med. 2011 May 29;9:83. doi: 10.1186/1479-5876-9-83.

5.

Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases.

Fifis T, Malcontenti-Wilson C, Amijoyo J, Anggono B, Muralidharan V, Nikfarjam M, Christophi C.

HPB (Oxford). 2011 Apr;13(4):246-55. doi: 10.1111/j.1477-2574.2010.00278.x. Epub 2011 Mar 2.

Supplemental Content

Loading ...
Support Center